1. Home
  2. RXO vs STVN Comparison

RXO vs STVN Comparison

Compare RXO & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RXO Inc.

RXO

RXO Inc.

HOLD

Current Price

$25.63

Market Cap

4.5B

Sector

N/A

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.68

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXO
STVN
Founded
2022
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Containers/Packaging
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.7B
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
RXO
STVN
Price
$25.63
$19.68
Analyst Decision
Hold
Buy
Analyst Count
13
3
Target Price
$16.33
$25.67
AVG Volume (30 Days)
1.5M
267.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.39%
EPS Growth
72.81
N/A
EPS
N/A
N/A
Revenue
$5,742,000,000.00
N/A
Revenue This Year
$0.49
$9.67
Revenue Next Year
$6.90
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
26.20
N/A
52 Week Low
$10.43
$12.89
52 Week High
$29.90
$28.00

Technical Indicators

Market Signals
Indicator
RXO
STVN
Relative Strength Index (RSI) 43.61 57.51
Support Level $25.28 $18.74
Resistance Level $29.24 $20.27
Average True Range (ATR) 1.36 0.78
MACD -0.17 -0.04
Stochastic Oscillator 14.22 55.63

Price Performance

Historical Comparison
RXO
STVN

About RXO RXO Inc.

RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: